Monitoring the efficacy of artemether-lumefantrine and artesunate-sulfadoxine/pyrimethamine combinations for treating uncomplicated <i>Plasmodium falciparum</i> malaria in Boali, Central African Republic. [PDF]
Diaman-Ronsone A +6 more
europepmc +1 more source
Structural and Functional Impact of the G340S Mutation in Plasmodium falciparum Ferredoxin NADP⁺ Reductase: In silico Analysis and Molecular Docking. [PDF]
Kiboi D, Muriithi B.
europepmc +1 more source
Pharmaceutical quality of artemether-lumefantrine in Rwanda's public health supply chain: a cross-sectional post-market surveillance study. [PDF]
Rutayisire R +7 more
europepmc +1 more source
Geographical Variation in Antimalarial Drug Resistance Marker Prevalence across the Southern African Elimination Eight Region. [PDF]
Raman J +43 more
europepmc +1 more source
Indole-based hybrids target both asexual parasites and gametocytes of <i>Plasmodium falciparum</i> and synergize with lumefantrine. [PDF]
Mohanty A +7 more
europepmc +1 more source
Experimental Evolution of Reduced Susceptibility to Artemether-Lumefantrine in <i>Plasmodium berghei</i> Following Serial Drug Pressure. [PDF]
Njoroge SM +7 more
europepmc +1 more source
A systematic review of lumefantrine
P. Shanmugasundaram +2 more
openaire +1 more source
Development of an Experimental Human Blood-Stage Model for Studying Plasmodium knowlesi. [PDF]
Gower JSE +21 more
europepmc +1 more source
Slowing the spread of treatment failure to artemisinin-based combination therapies in Uganda. [PDF]
Nguyen TD +12 more
europepmc +1 more source
Preparation, characterization and pre-clinical evaluation of artemether-lumefantrine-paracetamol (AL-P) loaded nanocarriers in the treatment of malaria. [PDF]
Muchonjo JK +4 more
europepmc +1 more source

